Drs. Brian Strahl, Professor of Biochemistry and Biophysics at UNC-Chapel Hill along with Or Gozani, Associate Professor at Stanford, and Mark Bedford, Professor of Molecular Carcinogenesis at the University of Texas are the scientific founders of EpiCypher, a company that develops and manufactures novel products and tools for epigenetics and chromatin biology research. As of earlier this month, the operations have been moved from Texas to UNC-Chapel Hill campus.
![image2](https://www.med.unc.edu/biochem/wp-content/uploads/sites/795/2018/07/strahl-epicypher-move-to-unc-image2.jpeg)